In patients with T2DM, the levels of IGF-1 may be influenced by insulin resistance and hyperglycemia, leading to a diminished anabolic effect on bone, which could potentially be one of the mechanisms underlying the increased prevalence of osteoporosis in these individuals (11). The gene discussed is IGF1; the disease is osteoporosis.